Preemptive dose reduction of warfarin in patients initiating metronidazole.

about

Preemptive dose reduction of warfarin in patients initiating metronidazole.

Item

http://www.wikidata.org/entity/Q42745596

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Preemptive dose reduction of warfarin in patients initiating metronidazole.

@en

Preemptive dose reduction of warfarin in patients initiating metronidazole.

@nl

type

Item

label

Preemptive dose reduction of warfarin in patients initiating metronidazole.

@en

Preemptive dose reduction of warfarin in patients initiating metronidazole.

@nl

prefLabel

Preemptive dose reduction of warfarin in patients initiating metronidazole.

@en

Preemptive dose reduction of warfarin in patients initiating metronidazole.

@nl

P1476

Preemptive dose reduction of warfarin in patients initiating metronidazole.

@en

P2093

Erin A Anderson

http://www.w3.org/2001/XMLSchema#string

Jason A Egge

http://www.w3.org/2001/XMLSchema#string

Matthew A Cantrell

http://www.w3.org/2001/XMLSchema#string

Robert F Shaw

http://www.w3.org/2001/XMLSchema#string

Ryan K Holt

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic overview of warfarin and its drug and food interactions.

Atrial fibrillation and stroke. Three new studies, three remaining questions.

Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Intracerebral hemorrhage secondary to a warfarin-metronidazole interaction.

Warfarin monitoring in ambulatory older individuals receiving antimicrobial therapy.

Impact of preemptive warfarin dose reduction on anticoagulation after initiation of trimethoprim-sulfamethoxazole or levofloxacin.

Frequency and clinical outcome of potentially harmful drug metabolic interactions in patients hospitalized on internal and pulmonary medicine wards: focus on warfarin and cisapride.

P304

35-39

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1515/DMDI.2010.002

http://www.w3.org/2001/XMLSchema#string

P433

1-4

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21417792

http://www.w3.org/2001/XMLSchema#string